Table 2.
Demographic characteristics of patients in the PrefMab and MabCute clinical studies who participated in the psychometric evaluation of RASQ
| Characteristic | Patients, n (%)
|
|
|---|---|---|
| PrefMab (n=294) | MabCute (n=262) | |
| Sex | ||
| Male | 152 (51.7) | 127 (48.5) |
| Female | 142 (48.3) | 135 (51.5) |
| Missing/no response | 0 | 0 |
| Age, years | ||
| Mean | 57.9 | 64.9 |
| SD | 13.1 | 10.8 |
| Median | 59 | 65 |
| Range | 18–80 | 36–91 |
| Ethnicity | ||
| White | 216 (73.7) | 224 (85.5) |
| Asian | 64 (21.8) | 0 |
| American Indian/Alaskan native | 2 (0.7) | 0 |
| Black | 2 (0.4) | 1 (0.4) |
| Native Hawaiian or other Pacific Islander | 1 (0.3) | 0 |
| Other | 8 (2.7) | 9 (3.4) |
| Missing/no response | 1 (0.1) | 28 (10.7) |
Abbreviations: RASQ, Rituximab Administration Satisfaction Questionnaire; SD, standard deviation.